Αρχική World News Peer-to-peer match-funding initiative raises over £4 million for cancer research

Peer-to-peer match-funding initiative raises over £4 million for cancer research

Women scientists in a lab looking at a Petri dish

The Cancer Research UK Challenge Fund, which we launched in the initial throes of the pandemic, will help to ensure we can continue funding vital research.

We launched The Cancer Research UK Challenge Fund in June 2020 to inspire our philanthropic community to support us as we entered one of the most challenging periods in our history. The peer-to-peer initiative was funded by four supporters, who together donated over £2 million. This was used to match donations from other supporters of £100,000 or more. Inspired by this opportunity to double the value and impact of their donation, 18 supporters responded, with some stretching their charitable commitments. They collectively donated an additional £2 million, resulting in a combined donated total of over £4 million to help ensure that we can continue to fund innovative cancer research.

When we launched the fund, we were still in the early stages of the pandemic. We feared a significant reduction in our ability to fund world-class research as our initial income forecasts projected a worrying financial picture. And so, we set about developing a plan for how to respond to a significant drop in annual income and yet remain at the forefront of the global fight against cancer. This involved making cuts to our research budget – which we knew would inevitably result in fewer discoveries, new treatments and clinical trials – while our income recovered. But it also presented us with an opportunity to reach out to some of our closest supporters at this critical time, and they responded immediately and enthusiastically.

Knowing that our money would be matched by other supporters meant we could double the impact of our gift

While our income losses remain significant, our determination to beat cancer has never faltered. The £4 million these supporters collectively contributed, as well as donations from our broader community of supporters, means we can continue funding life-saving research projects led by some of the most talented scientists from around the world, who have worked tirelessly throughout the pandemic to reduce the devastating global impact of cancer.

Two supporters who gave through the fund are Nick and Annette Razey. “We’ve had people we love experience and die from various types of cancer,” they told us. “And as Cancer Research UK supports research into all types of cancer, we know our donation will be used where the need is greatest. Knowing that our money would be matched by other supporters meant we could double the impact of our gift.”

Our chief executive, Michelle Mitchell, offered: “I’d like to say a huge thank you to our Challenge Fund supporters for stepping up at such a critical time and responding so generously. The investments we’ve made in research and policy over the decades have brought us so far. And it is only with the continued backing of all our supporters, that we’ll realise a world in which a cancer diagnosis is no longer feared, treatments are precise and targeted, cancer is detected earlier or prevented entirely, and cancer survival is a given. Cancer Research UK is the largest charitable funder of cancer research in the world and we will stay at the forefront of the global fight against cancer.”

– Joanna Lewin, Philanthropy Communications Specialist at Cancer Research UK

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

10 Ways You Can Nurture A More Sustainable Garden

Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the...

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell...

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit [ESMO Virtual Plenary Press Release]

VP6-2021 - IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk,...

Breaking News: Supreme Court Upholds the Affordable Care Act

It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...